University of Zurich: COVID-19 trials

The registry lists 11 COVID-19 studies with University of Zurich as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 3 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pycnogenol® in Post-COVID-19 ConditionCompletedNCT05890534Phase 3
• Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness SurvivorsStatus unknownNCT04881266
• Clinical Efficiency of Surgical Masks and Filtering Face-piece 2 MasksStatus unknownNCT04823351Not applicable
• Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19Status unknownNCT04613986Not applicable
• Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress SyndromeStatus unknownNCT04597853
• COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School ChildrenCompletedNCT04448717
• Microbiota in COVID-19 Patients for Future Therapeutic and Preventive ApproachesStatus unknownNCT04410263
• Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19TerminatedNCT04400799Phase 3
• The Global PCHF-COVICAV RegistryStatus unknownNCT04390555
• The RIsk Stratification in COVID-19 Patients in the ICU RegistryActive, not recruitingNCT04357275
• Sevoflurane in COVID-19 ARDS (SevCov)CompletedNCT04355962Phase 3